Shenzhen Weiguang Biological Products Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1.38% vs -0.57% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -29.52% vs -6.62% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "221.90",
          "val2": "225.00",
          "chgp": "-1.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.20",
          "val2": "90.80",
          "chgp": "-55.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.30",
          "val2": "4.60",
          "chgp": "-6.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.80",
          "val2": "43.70",
          "chgp": "-29.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "181.40%",
          "val2": "242.10%",
          "chgp": "-6.07%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.70% vs 57.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.78% vs 79.60% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,197.60",
          "val2": "1,044.10",
          "chgp": "14.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "438.50",
          "val2": "327.60",
          "chgp": "33.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "22.90",
          "val2": "15.30",
          "chgp": "49.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.10",
          "val2": "0.70",
          "chgp": "-2,114.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "254.00",
          "val2": "217.50",
          "chgp": "16.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "265.60%",
          "val2": "228.10%",
          "chgp": "3.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

221.90

225.00

-1.38%

Operating Profit (PBDIT) excl Other Income

40.20

90.80

-55.73%

Interest

4.30

4.60

-6.52%

Exceptional Items

0.00

0.00

Consolidate Net Profit

30.80

43.70

-29.52%

Operating Profit Margin (Excl OI)

181.40%

242.10%

-6.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -1.38% vs -0.57% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -29.52% vs -6.62% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,197.60

1,044.10

14.70%

Operating Profit (PBDIT) excl Other Income

438.50

327.60

33.85%

Interest

22.90

15.30

49.67%

Exceptional Items

-14.10

0.70

-2,114.29%

Consolidate Net Profit

254.00

217.50

16.78%

Operating Profit Margin (Excl OI)

265.60%

228.10%

3.75%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 14.70% vs 57.05% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.78% vs 79.60% in Dec 2023

All Annual Results